Views & Analysis Exclusive: Brexit likely to cause long-term damage to UK pha... Exclusive survey finds concerns about future of UK pharma industry
News Government to launch post-Brexit industrial strategy in spri... The UK government is to launch a new industrial strategy aimed at helping the country thrive post-Brexit, and life sciences will be ‘centre stage’ when it is unveiled in the spring.
Views & Analysis ‘Quickie divorce’ Brexit not an option for medicines, says U... The UK government wants a 'bespoke' deal for pharma - but the EU has other ideas.
News Trump elected president: what now for pharma? Trump has called for Medicare to negotiate drug prices.
News Nissan stays in UK - but will Japanese pharma? Japanese R&D investment could follow EMA out of UK - experts.
News UK must draw up post-Brexit pharma strategy Big pharma could take its money elsewhere post Brexit, report warns.
News Takeda's TYK2 drug bests BMS's Sotyktu in psoriasis contest New data with Takeda's TYK2 inhibitor zasocitinib suggest it is significantly more effective than BMS's Sotyktu in the treatment of psoriasis.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
